Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre

BACKGROUND: Glycogen storage disease type Ib (GSD Ib) is a severe disorder of carbohydrate metabolism due to bi-allelic variants in SLC37A4. It is associated with neutropaenia and neutrophil dysfunction, which has recently been attributed to the accumulation of 1,5-anhydroglucitol-6-phosphate (1,5AG...

Descripción completa

Detalles Bibliográficos
Autores principales: Halligan, Rebecca K., Dalton, R. Neil, Turner, Charles, Lewis, Katherine A., Mundy, Helen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096769/
https://www.ncbi.nlm.nih.gov/pubmed/35549996
http://dx.doi.org/10.1186/s13023-022-02345-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096769/
https://www.ncbi.nlm.nih.gov/pubmed/35549996
http://dx.doi.org/10.1186/s13023-022-02345-2

Ejemplares similares